ATG5 and cancer: In one study, reducingautophagy with siRNAs that targeted Beclin-1or ATG-5 improved cancer immunotherapy as shown by a recovery in thesensitivity of hypoxic tumor cells to Cytolytic T lymphocytes (CTL)-mediatedlysis.